Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-17251

ABSTRACT: Transcription profiling by array of human primary hepatocytes after treatment with pirinixic acid

OTHER RELATED OMICS DATASETS IN: PRJNA123587PRJNA123585PRJNA118935

PROVIDER: E-GEOD-17251 | ExpressionAtlas | 2015-07-29

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-17251-analysis-methods.tsv	Tabular
	E-GEOD-17251-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-17251-configuration.xml	Xml
	E-GEOD-17251-percentile-ranks.tsv	Tabular
	E-GEOD-17251.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 60

Similar Datasets

Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytes

2014-02-09 | GSE27183 | GEO

Real-time quantitative PCR miRNA analysis of human hepatocytes

Project description:Primary human hepatocytes were treated with compounds modulating steatosis: palmitic acid, compound C and metformin qPCR miRNA expression profiling. Hepatocytes were treated as indicated in the summary. Equal amount total RNA was pooled prior to miRNA expression analysis

2020-02-11 | GSE145039 | GEO

Homo sapiens

Project description:Primary hepatocytes with glucagon treatment expression profiling

| PRJNA282088 | ENA

Homo sapiens

Project description:Gene expression profiling of primary human hepatocytes after berberine chloride treatment

| PRJNA231939 | ENA

Homo sapiens

Project description:MicroRNA expression profiling of primary human hepatocytes after berberine chloride treatment

| PRJNA231940 | ENA

Etomoxir as a Promiscuous Chemoproteomic Probe.

Project description:Primary hepatocytes from WT or Pex5KO mouse livers were treated with 100uM clickable etomoxir analogues and the proteins bound to etomoxir were pulled down and identified. The small molecule inhibitor etomoxir has been used for many years as a specific inhibitor of Cpt1 but these data show that etomoxir binds a large array of proteins and is not appropriate as a tool for evaluating the biological effects of fatty acid oxidation. Primary hepatocytes were treated with 100uM clickable etomoxir analogues and the proteins bound to etomoxir were pulled down and identified. The small molecule inhibitor etomoxir has been used for many years as a specific inhibitor of Cpt1 but these data show that etomoxir binds a large array of proteins and is not appropriate as a tool for evaluating the biological effects of fatty acid oxidation.

2024-10-17 | PXD045866 | Pride

Protein data in PHH after VPA-treatment

Project description:LC-MS/MS protein data of Primary Human Hepatocytes (PHH) exposed to Valproic Acid (VPA) for 3 days daily and 3 days daily exposure followed by 3 days washout.

2018-02-27 | PXD007538 | Pride

Genome wide binding and transcriptome analysis of human FXR in primary human hepatocytes [HTS]

Project description:We report the genome-wide profiling of FXR binding by ChIP-seq from GW4064 or DMSO treated primary human hepatocytes. We reported altered RNA expression profiles in primary human hepatocypes upon GW4064 treatment compared to DMSO control by RNA-seq. We also reported the altered RNA expression profiles in livers from WT C57BL/6J mice upon GW4064 treatment compared to vehicle control. Primary human hepatocytes were treated with 5uM GW4064 or DMSO control, 1 hour later, cells were fixed and collected for chromatin isolation. 24 hours post treatment, cells were isolated for RNA isolation. This submission represents HTS component of study.

2014-07-24 | E-GEOD-57227 | biostudies-arrayexpress

Comparative gene expression profiles induced by PPARM-NM-3 and PPARM-NM-1/M-NM-3 agonists in human hepatocytes

Project description:Transcriptomic profiling of primary human hepatocytes after treatment with 2 glitazones (TRO and ROSI) and 2 glitazars (MURA and TESA) Singe-Channel Samples: We have analysed changes in gene expression profiles in primary human hepatocytes after a 24 h treatment with various concentrations of glitazones and glitazars Dual-Channel Samples: We have analysed changes in gene expression profiles in primary human hepatocytes and differentiated human hepatoma HepaRG cells after a 24 h treatment with various concentrations of glitazones and glitazars Singe-Channel Samples: 5 condition experiments, control, TRO (3 concentrations) , ROSI (3 concentrations) , MURA (3 concentrations) and TESA (1 concentration) , biological replicates:2 to 4 Dual-Channel Samples: 5 condition experiments, control, TRO (3 concentrations) , ROSI (4 concentrations) , MURA (4 concentrations) and TESA (1 concentration) , biological replicates: 3

2014-02-09 | E-GEOD-27183 | biostudies-arrayexpress

Induction of changes in primary human hepatocytes by valproic acid

Project description:Induction of changes in primary human hepatocytes by valproic acid

| PRJNA328467 | ENA